If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Forteo ® (teriparatide injection)
20-mcg daily dose in a 2.4-mL prefilled delivery deviceThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Teriparatide should be administered as a subcutaneous injection into the thigh or abdominal wall.1
In clinical trials, teriparatide was injected subcutaneously into the patient’s thigh or abdominal wall.1
The upper arm is an acceptable area for subcutaneous injection; however, there are no data available on the injection of teriparatide at this site.
There is no data available on the safety or efficacy of intravenous or intramuscular injection of teriparatide.
Please review the Forteo® Pen User Manual for instructions on how to properly inject teriparatide.
1Forteo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: November 11, 2019
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST